Tuesday 27 June 2017
Advancing Neonatal Care
Infant trial data has shown that Incereb’s Neon EEG device can improve treatment for babies in neonatal care. As a world-renowned pregnancy research centre, Infant played a key role in securing Incereb’s funding and distribution.
Incereb’s CEO Jim Roche called their collaboration with Infant “enormously significant” in attracting US distribution. Clinicians in the United States, Mr. Roche noted, recognised Infant as a leader in the field, proving the marketability of the Neon EEG device.
Life Changing Research
Infant are very proud of their collaboration with Incereb, which shows the power of research to change the lives of mothers and babies worldwide.
To read The Business Post’s full article on Incereb’s success, click here (subscription required).